Latest Breaking News On - கீந் தொழில்நுட்பங்கள் - Page 5 : comparemela.com

Published: Mar 12, 2021 Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston Facility GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2021 (GLOBE NEWSWIRE) Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intranasal vaccine candidate for COVID-19, at its facility near Houston, Texas. “Manufacturing capacity for COVID-19 vaccines has been severely constrained, and this limitation has presented considerable challenges for vaccine developers,” said Dr. Vyjayanthi Krishnan, Ph.D., Vice President of Product Development for Altimmune. “By expanding our Lonza collaboration and commissioning our own d

United statesMartina ribar hestericovDirk oehlersAlberto santagostinoVipink gargVyjayanthi krishnanStacey jurchisonHead of external communicationsLonza group ltdAltimmune incSwiss exchangeUniversity of alabama at birminghamExchange commissionSingapore exchange securities trading limitedProduct development for altimmuneDedicated suite